-
-
About the Cover:On the cover: An injectable silk fibroin hydrogel with encapsulated SBA-15 for the co-delivery of a vascular disrupting agent, combretastatin A4 disodium phosphate (CA4P), and a chemotherapeutic agent, doxorubicin hydrochloride (DOX), was prepared. Such hydrogels showed two different types of drug release behavior and held great potential for drug delivery and tumor therapy. [Zhengzhong Shao et al. on page 1023-1029.]
-
-
Current Issue
Review
Article